Development of Rift Valley fever (RVF) vaccine by genetic joining of the RVF-glycoprotein Gn with the strong adjuvant subunit B of cholera toxin (CTB) and expression in bacterial system-Reference-Cited by-同舟云学术

Development of Rift Valley fever (RVF) vaccine by genetic joining of the RVF-glycoprotein Gn with the strong adjuvant subunit B of cholera toxin (CTB) and expression in bacterial system

Published:2019-11 Issue:7 Volume:26 Page:1676-1681
ISSN:1319-562X
Container-title:Saudi Journal of Biological Sciences
language:en
Short-container-title:Saudi Journal of Biological Sciences

Author:

Ibrahim Essam H.,Taha Ramadan,Ghramh Hamed A.,Kilany Mona

Funder

King Khalid University

Publisher

Elsevier BV

Subject

General Agricultural and Biological Sciences

Reference36 articles.

1. Vaccinology: past achievements, present roadblocks and future promises;Andre;Vaccine,2003

2. Vertical transmission of Rift Valley fever virus without detectable maternal viremia;Antonis;Vector-Borne Zoonotic Dis.,2013

3. Risk Factors for Severe Rift Valley Fever Infection in Kenya, 2007;Anyangu;Am. J. Trop. Med. Hyg.,2010

4. Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli;Areas;Protein Expr Purif,2002

5. Comparison of two recombinant systems for expression of cholera toxin B subunit from Vibrio cholerae;Bakhshi;Indian J. Med. Microbiol.,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and safety studies of an inactivated vaccine against Rift Valley fever;Acta Tropica;2022-08

2. A potential delivery system based on cholera toxin: A macromolecule carrier with multiple activities;Journal of Controlled Release;2022-03

3. Expression of Bordetella pertussis Antigens Fused to Different Vectors and Their Effectiveness as Vaccines;Vaccines;2021-05-21

4. Uncertain Quantification of Immunological Memory to Yellow Fever Virus;2020 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2020-12-16

5. Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals;BMC Bioinformatics;2020-12